<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01819740</url>
  </required_header>
  <id_info>
    <org_study_id>CSPT/URO/2013/PROSTATE</org_study_id>
    <nct_id>NCT01819740</nct_id>
  </id_info>
  <brief_title>Analysis of a New Biomarker for Prostate Cancer Diagnosis</brief_title>
  <acronym>HEM</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Corporacion Parc Tauli</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Corporacion Parc Tauli</source>
  <brief_summary>
    <textblock>
      The aim of our study is to determine if the levels of the &quot;HEM&quot; substance in seminal plasma
      are associated with the presence of prostate cancer in transrectal prostate biopsy.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">April 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>substance &quot;HEM&quot; concentration in seminal plasma (mEq/L measured by spectro-photometry</measure>
    <time_frame>1 hour</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">28</enrollment>
  <condition>Patients With Suspected Prostate Cancer</condition>
  <arm_group>
    <arm_group_label>patients with suspected prostate cancer</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>determine the levels of the &quot;HEM&quot; substance in seminal plasma</intervention_name>
    <arm_group_label>patients with suspected prostate cancer</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Men with clinical or laboratory suspected of prostate cancer attends in Parc Tauli
        Universitary Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical or laboratory suspected of prostate cancer

        Exclusion Criteria:

          -  Inability to ejaculate
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>45 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miriam Barrio-Muñoz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Universitario Parc Tauli de Sabadell. Spain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miriam Barrio-Muñoz</last_name>
    <phone>34 93 723 10 10</phone>
    <email>mbarrio6@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Universitario Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Miriam Barrio-Muñoz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 25, 2013</study_first_submitted>
  <study_first_submitted_qc>March 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2013</study_first_posted>
  <last_update_submitted>March 27, 2013</last_update_submitted>
  <last_update_submitted_qc>March 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital de Sabadell</investigator_affiliation>
    <investigator_full_name>MIRIAM BARRIO MUÑOZ</investigator_full_name>
    <investigator_title>UROLOGY RESIDENT</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

